デフォルト表紙
市場調査レポート
商品コード
1029050

CROのインド市場:サービスタイプ別、治療適応別、エンドユーザー別、地域別 - 2027年までの予測

India CRO Market Information, By Services Type ; By Therapeutic Application ; By End-Users ; By Region - Forecast to 2027

出版日: | 発行: Blueweave Consulting & Research Private Limited | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円
CROのインド市場:サービスタイプ別、治療適応別、エンドユーザー別、地域別 - 2027年までの予測
出版日: 2021年08月21日
発行: Blueweave Consulting & Research Private Limited
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インドのCRO市場は、近年勢いを増しており、2020年に9億5,680万米ドルと評価され、2017年~2020年のCAGRで5.51%の成長を遂げています。市場は、2027年までに18億8,300万米ドルに達し、予測期間中のCAGRで10.75%の成長が予測されています。インドのCRO市場の成長には、腫瘍研究分野の急成長、製薬業界の活況、インド政府からの支援の増加などが要因として挙げられます。

当レポートでは、インドのCRO市場について調査分析し、業界考察、市場概要、COVID-19の影響、競合情勢、主要企業について、体系的な情報を提供しています。

目次

第1章 調査の枠組み

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドのCRO市場 - 業界考察

  • DROC分析
    • 成長促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • 最近の動向
  • 技術の進歩
  • M&A、提携、JV、パートナーシップ
  • 規制の考察
  • ポーターのファイブフォース分析

第5章 インドのCRO市場概要

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
      • 臨床試験
      • 製品開発
      • プロセス開発
      • 上市後の調査
      • 品質モニタリング
      • その他
    • 治療適応別
      • 腫瘍
      • 心血管
      • 神経
      • 腎臓・泌尿器
      • その他
    • エンドユーザー別
      • 製薬/バイオ製薬企業
      • 医療機器企業
      • 学術機関
    • 地域別
      • 東部
      • 北部
      • 南部
      • 西部

第6章 インドのCRO市場に対するCOVID-19の影響

第7章 競合情勢

  • 主要企業とその提供リスト
  • 市場/ランキングシェア分析
  • 競合ベンチマーキング:パラメーター別

第8章 企業プロファイル

  • Pharmaceutical Product Development, LLC,
  • IQVIA RDS (India) Private Limited
  • Parexel International (India) Pvt. Ltd.
  • Syngene International Limited
  • Covance India Pharmaceutical Services Pvt. Ltd
  • Siro Clinpharm Private Limited
  • Vimta Labs Limited
  • Aizant Drug Research Solutions Private Limited
  • Piramal Pharma Solutions
  • Synapse Labs Private Limited
  • Other Prominent Players

第9章 戦略的提言

図表

List of Tables

  • Table 1 India CRO Market Size (USD Million), By Service Type, By Value, 2017-2027
  • Table 2 India CRO Market Size (USD Million), By Therapeutic Application, By Value, 2017-2027
  • Table 3 India CRO Market Size (USD Million), By End-Users, By Value, 2017-2027
  • Table 4 India CRO Market Size (USD Million), By Region, By Value, 2017-2027
  • Table 5 List of Key Players and Their Offerings
  • Table 6 Competitive Benchmarking, by Operating Parameters
  • Table 7 Pharmaceutical Product Development, LLC Overview
  • Table 8 Pharmaceutical Product Development, LLC Financial Analysis (USD Millions)
  • Table 9 IQVIA RDS (India) Private Limited Overview
  • Table 10 IQVIA Holdings Inc. Financial Analysis (USD Millions)
  • Table 11 Parexel International (India) Pvt. Ltd. Overview
  • Table 12 Syngene International Limited Overview
  • Table 13 Syngene International Limited Financial Analysis (USD Millions)
  • Table 14 Covance India Pharmaceutical Services Pvt. Ltd. Overview
  • Table 15 LabCorp Drug Development (Covance) Financial Analysis (USD Millions)
  • Table 16 Siro Clinpharm Private Limited Overview
  • Table 17 Vimta Labs Limited Overview
  • Table 18 Vimta Labs Limited Financial Analysis (USD Millions)
  • Table 19 Aizant Drug Research Solutions Private Limited Overview
  • Table 20 Piramal Pharma Solutions Overview
  • Table 21 Piramal Enterprises Limited Financial Analysis (USD Millions)
  • Table 22 Synapse Labs Private Limited Overview

List of Figures

  • Figure 1 India CRO Market Segmentation
  • Figure 2 India CRO Market Size (USD Million)
  • Figure 3 India CRO Forecast Market Size (USD Million)
  • Figure 4 India CRO Market, By Distribution Channel (in %), 2020
  • Figure 5 Porters Five Forces Analysis
  • Figure 6 India CRO Market Size, By Value (USD Million), 2017-2027
  • Figure 7 India CRO Market Share (%), By Service Type, By Value, 2017-2027
  • Figure 8 India CRO Market Share (%), By Therapeutic Application, By Value, 2017-2027
  • Figure 9 India CRO Market Share (%), By End-Users, By Value, 2017-2027
  • Figure 10 India CRO Market Share (%), By Region, By Value, 2017-2027
  • Figure 11 India CRO Market: Leading Companies
  • Figure 12 India CRO Market: Market Share Analysis, 2020

"

目次
Product Code: BWC2070

India CRO Market Set to Hit New Highs- Projected to Reach Worth USD 1,883.0 Million in 2027

A study recently conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the India CRO Market has gained momentum in recent years with a CAGR of 5.51%, in value terms, over the historical period 2017-2020 and a market valuation of USD 956.8 million in 2020. The market is further expected to reach USD 1,883.0 million by 2027 with a CAGR of 10.75% during the forecast period. The rapidly growing field of oncology studies in the country, along with the booming pharmaceutical industry and increasing support from the Indian government are some of the factors contributing to the growth of the India CRO market. According to the Indian Council of Medical Research (ICMR), the number of cancer cases in Indian men are expected to go up from 6,79,421 in 2020 to 7,63,575 by 2025, which is expected to propel oncology trials in the country. Moreover, the low cost of trials in the country is another reason for the thriving CRO market in the country.

The Rise in Pharmaceutical and Biotech Manufacturing Favoring India CRO Market

Contract research in India is predicted to grow in the near future since India's rapidly improving business environment is conducive to its growth. A combination of cheap land and labor, along with government regulations, is attracting companies to set up their offices in India, which is driving the market growth of the India CRO market. For instance, the rise in pharmaceutical and biotech manufacturing, as well as IT-supported research and development, has resulted in promising outsourcing business prospects in a variety of other areas, such as clinical trials, data management, and statistical analysis. Presently, India has good advantages for clinical research setup.

There are 3,000 drug companies and 10,500 manufacturing units in India as the country is the world's largest producer of vaccines and supplies 50% of the global demand for vaccines. Thus. the Union Budget 2021-2022 has earmarked USD 10.35 billion to the Ministry of Health and Famil1y Welfare, and USD 365.68 billion to the Department of Health Research, in order to strengthen India's pharmaceutical industry and invest more in research. These are the key factors driving the growth of India CRO market.

Increasing Number of Clinical Trials Driving the Market Growth

In addition to the increase in clinical trials, the growth in outsourcing of clinical trials, particularly Phase II and Phase III trials, and the collaborations between key players and clinical service providers to minimize failures are the primary factors that contribute to the increasing share for clinical research services. While the DCGI (Drug Controller General of India) only approved only 17 clinical trials in 2013, it approved 97 clinical trials in 2017, a rise of 400%. In India, aging demographics, the growing prevalence of chronic diseases, the development of new drugs, and the growing acceptance of evidence-based medicine for various therapeutic areas all contribute to the growth of the India CRO market. India is the largest producer of generic drugs. Moreover, the country supplies 50% of the global demand for vaccines. Furthermore, India ranks 3rd globally in terms of pharmaceutical production. The factors cited above are creating lucrative growth opportunities for the India CRO market.

Based on Therapeutic Application, Oncology Dominates the India CRO Market

CROs assist firms and organizations with oncology trials in a variety of ways, including meeting regulatory submission deadlines, determining acceptable oncology research designs, reporting to safety monitoring committees, and real-time oncology review (RTOR).As per the National Centre for Disease Informatics and Research and the Indian Council of Medical Research (ICMR), the total number of cancer cases in 2020 was estimated at 13.9 lakh. The number is likely to grow by 15.7 lakh by 2025.The prevalence of cancer is marginally higher in women, with 7,12,758 cases reported in 2020. The number is likely to reach 8,06,218 in 2025. The growing number of cancer cases in the country is expected to encourage a growing number of oncology studies and trials, supporting the growth of the India CRO market in the coming years.

India CRO Market: Regional Insights

India CRO market is segmented into four regions- East India, North India, South India, and West India. Southern India caters to the highest share in the India CRO market. South India is the largest and fastest growing region in the Indian CRO market. However, North India is expected to register significant growth in the upcoming years. As cancer prevalence in the area increases, the region is likely to witness an increase in cancer studies and clinical trials, increasing support from the State governments, as well as the rise of global leaders. Himachal Pradesh has emerged as the pharmaceutical hub of the northern region, according to the Indian State Industries Minister. The state caters to 35% of Asia's demand for pharmaceutical products. The growing pharma activity in the Northern part of India is expected to function as a driver for the India CRO market.

Impact of COVID-19

The World Health Organization has declared the novel corona virus (COVID-19) to be a pandemic. COVID-19 is wreaking havoc on economies and livelihoods, as well as reducing production operations due to a labor force reduction. Developing countries are particularly vulnerable. In 2020 the corona virus pandemic has, unsurprisingly, proved to be the primary driver behind several trends across the healthcare industry. The race to develop a COVID-19 vaccine throughout 2020 highlighted the critical importance of viral vectors for the vaccine industries in delivering successful vaccines and pharmaceutical the rapies. Therefore, a race began among the vaccine manufacturing companies to deliver the most influential vaccine, which made clinical trials a lucrative opportunity for CROs.

Competitive Benchmarking

The India CRO market is moderately consolidated with a small number of players covering a larger share of the market. Consequently, the newer entrants find it difficult to establish themselves in the region and offer exclusive services to Indian customers. The major companies in the India CRO market include IQVIA Consulting and Information Services India Private Limited (Quintiles IMS Holdings, Inc.), PAREXEL International (India) Pvt Ltd., Syngene International Ltd., Pharmaceutical Product Development LLC, Siro Clinpharm Pvt. Ltd., Clininvent Research Pvt. Ltd., VIMTA Labs Ltd., Bilcare Limited, Aizant Drug Research Solutions Private Limited, Piramal Pharma Solutions, Synapse Labs Pvt. Ltd., Eurofins Scientific, Covance India Pharmaceutical Services Pvt. Ltd., Abiogenesis Clinpharm Pvt. Ltd., Laurus Labs, Neuland Laboratories Ltd., Accustest Research Laboratories Pvt Ltd.,and other prominent players.

Recent Developments

In June 2021, Aragen Life Sciences announced an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim. With this preferred partnership, Boehringer Ingelheim, a leading pharmaceutical company that is committed to innovation in research, can integrate multiple design elements into chemistry, synthesize and profile diverse chemotypes against targets of interest, and then characterize them over time. Aragen would be dedicating a sizeable portion of its campus in Hyderabad to support this alliance.

Don't miss the business opportunity of India CRO market. Consult our analysts, gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the India CRO market size & forecast. The report promises to provide recent technology trends of the India CRO market and industry insights which help decision-makers to make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges and competitive dynamics of the market.

About Us

BlueWeave Consulting provides all kinds of Market Intelligence (MI) Solutions to the businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality inputs and nourishing the long-lasting relationships with its clients. We are one of the promising digital MI solutions company providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt. Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.5. Market Size Estimation
  • 2.6. Assumption for the Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. India CRO Market - Industry Insights

  • 4.1. DROC Analysis
    • 4.1.1. Growth Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. Recent Developments
  • 4.3. Technological Advancement
  • 4.4. M&A's, Collaborations, JVs and Partnerships
  • 4.5. Regulatory Insights
  • 4.6. Porter's Five Forces Analysis

5. India CRO Market Overview

  • 5.1. Market Size & Forecast, 2017-2027
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Services Type
      • 5.2.1.1. Clinical trials
      • 5.2.1.2. Product Development
      • 5.2.1.3. Process Development
      • 5.2.1.4. Post-Marketing Surveillance
      • 5.2.1.5. Quality Monitoring
      • 5.2.1.6. Others
    • 5.2.2. By Therapeutic Application
      • 5.2.2.1. Oncology
      • 5.2.2.2. Cardiovascular
      • 5.2.2.3. Neurology
      • 5.2.2.4. Nephrology and Urology
      • 5.2.2.5. Others
    • 5.2.3. By End-User
      • 5.2.3.1. Pharmaceutical/Biopharmaceutical Companies
      • 5.2.3.2. Medical devices Companies
      • 5.2.3.3. Academic Institutes
    • 5.2.4. By Region
      • 5.2.4.1. Eastern India
      • 5.2.4.2. Northern India
      • 5.2.4.3. Southern India
      • 5.2.4.4. Western India

6. Impact of COVID-19 on India CRO Market

7. Competitive Landscape

  • 7.1. List of Key Players and Their Offerings
  • 7.2. Market/Ranking Share Analysis, 2020
  • 7.3. Competitive Benchmarking, By Operating Parameters

8. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 8.1. Pharmaceutical Product Development, LLC,
  • 8.2. IQVIA RDS (India) Private Limited
  • 8.3. Parexel International (India) Pvt. Ltd.
  • 8.4. Syngene International Limited
  • 8.5. Covance India Pharmaceutical Services Pvt. Ltd
  • 8.6. Siro Clinpharm Private Limited
  • 8.7. Vimta Labs Limited
  • 8.8. Aizant Drug Research Solutions Private Limited
  • 8.9. Piramal Pharma Solutions
  • 8.10. Synapse Labs Private Limited
  • 8.11. Other Prominent Players

9. Strategic Recommendation

*Financial details of unlisted companies will be available as per data availability in final deliverable

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable